Zobrazeno 1 - 10
of 1 129
pro vyhledávání: '"Yutaka, Yamamoto"'
Autor:
Shin Takahashi, Nobuaki Sato, Kouji Kaneko, Norikazu Masuda, Masaaki Kawai, Hisashi Hirakawa, Tadashi Nomizu, Hiroji Iwata, Ai Ueda, Takashi Ishikawa, Hiroko Bando, Yuka Inoue, Takayuki Ueno, Shinji Ohno, Makoto Kubo, Hideko Yamauchi, Masahiro Okamoto, Eriko Tokunaga, Shunji Kamigaki, Kenjiro Aogi, Hideaki Komatsu, Masahiro Kitada, Yasuaki Uemoto, Tatsuya Toyama, Yutaka Yamamoto, Toshinari Yamashita, Takehiro Yanagawa, Hiroko Yamashita, Yoshiaki Matsumoto, Masakazu Toi, Minoru Miyashita, Takanori Ishida, Fumiyoshi Fujishima, Satoko Sato, Takuhiro Yamaguchi, Fumiaki Takahashi, Chikashi Ishioka
Publikováno v:
Translational Oncology, Vol 48, Iss , Pp 102060- (2024)
The TP53 signature is considered a predictor of neoadjuvant chemotherapy (NAC) response and prognostic factor in breast cancer. The objective of this study was to confirm TP53 signature can predict pathological complete response (pCR) and prognosis i
Externí odkaz:
https://doaj.org/article/74d2b36fc35b41b88125efdc9ac30b6a
Publikováno v:
BJUI Compass, Vol 5, Iss 3, Pp 356-358 (2024)
Externí odkaz:
https://doaj.org/article/e485468051254902a3b60a32bcb2921e
Autor:
Misato Masuyama, Norikazu Masuda, Hidetoshi Kawaguchi, Yutaka Yamamoto, Shigehira Saji, Takahiro Nakayama, Kenjiro Aogi, Keisei Anan, Shoichiro Ohtani, Nobuaki Sato, Toshimi Takano, Eriko Tokunaga, Seigo Nakamura, Yoshie Hasegawa, Masaya Hattori, Tomomi Fujisawa, Satoshi Morita, Miki Yamaguchi, Toshinari Yamashita, Daisuke Yotsumoto, Masakazu Toi, Shinji Ohno
Publikováno v:
Cancer Medicine, Vol 12, Iss 17, Pp 17718-17730 (2023)
Abstract Background The role of endocrine therapy in the treatment of patients in a postmenopausal hormonal state and with estrogen receptor (ER)‐positive, human epidermal growth factor receptor 2 (HER2)‐positive advanced or metastatic breast can
Externí odkaz:
https://doaj.org/article/caeec8fc425642ad8dfd47e91b38c921
Autor:
Keisuke Tsuchida, Masahiro Takahashi, Takara Nakazawa, Sho Kurihara, Kazuhisa Yamamoto, Yutaka Yamamoto, Hiromi Kojima
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 6, p 1780 (2024)
Background: The indications for transcanal endoscopic ear surgery (TEES) for middle ear cholesteatoma have expanded for cases involving mastoid extension. However, TEES is not indicated for all cases with mastoid extension. In addition, predicting th
Externí odkaz:
https://doaj.org/article/008a85d73a9140938fb45afea0544698
Autor:
Masataka Sawaki, Naruto Taira, Yukari Uemura, Tsuyoshi Saito, Shinichi Baba, Kokoro Kobayashi, Hiroaki Kawashima, Michiko Tsuneizumi, Noriko Sagawa, Hiroko Bando, Masato Takahashi, Miki Yamaguchi, Tsutomu Takashima, Takahiro Nakayama, Masahiro Kashiwaba, Toshiro Mizuno, Yutaka Yamamoto, Hiroji Iwata, Tatsuya Toyama, Koichiro Tsugawa, Takuya Kawahara, Hirofumi Mukai
Publikováno v:
Breast, Vol 66, Iss , Pp 245-254 (2022)
Purpose: To gauge the effects of treatment practices on prognosis for older patients with HER2-positive early breast cancer, particularly to determine whether adjuvant trastuzumab alone can offer benefit over no adjuvant therapy. This is a prospectiv
Externí odkaz:
https://doaj.org/article/a945b7265854493eb752770a4643139b
Publikováno v:
Journal of Otolaryngology - Head and Neck Surgery, Vol 51, Iss 1, Pp 1-7 (2022)
Abstract Background Tympanoplasty using the interlay technique has rarely been reported in transcanal endoscopic ear surgery, unlike the underlay technique. This is because many surgeons find it challenging to detach the epithelial layer of the tympa
Externí odkaz:
https://doaj.org/article/16ed81af5730462cb9cf75aba1185d6d
Autor:
Yasuo Oguma, Makoto Hosono, Kaoru Okajima, Eri Inoue, Kiyoshi Nakamatsu, Hiroshi Doi, Tomohiro Matsuura, Masahiro Inada, Takuya Uehara, Yutaro Wada, Aritoshi Ri, Yutaka Yamamoto, Kazuhiro Yoshimura, Hirotsugu Uemura, Yasumasa Nishimura
Publikováno v:
Radiation, Vol 2, Iss 3, Pp 273-284 (2022)
The optimal sequence and combination of radium-223 therapy (Ra-223) for castration-resistant prostate cancer with bone metastasis (mCRPC) remain unclear. This study aimed to explore the prognostic factors after Ra-223 administration and to determine
Externí odkaz:
https://doaj.org/article/67ef6462d7574b8b954161441263d4db
Autor:
Aiko Sueta, Masako Takeno, Lisa Goto-Yamaguchi, Mai Tomiguchi, Toko Inao, Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-7 (2022)
Abstract Background Cowden syndrome is a rare autosomal-dominant disease with a high risk of malignant tumors of the breast, commonly caused by germline mutations in the PTEN gene. Most breast cancers related to Cowden syndrome showed typically a slo
Externí odkaz:
https://doaj.org/article/8ee2626e84824af794ce5c6fd793754c
Autor:
Yasunori Akashi, Yutaka Yamamoto, Mamoru Hashimoto, Shogo Adomi, Kazutoshi Fujita, Keisuke Kiba, Takafumi Minami, Kazuhiro Yoshimura, Akihide Hirayama, Hirotsugu Uemura
Publikováno v:
Cancers, Vol 15, Iss 24, p 5780 (2023)
Introduction: Immune checkpoint inhibitor (ICI) therapy has significantly improved the prognosis of some patients with advanced urothelial carcinoma (UC), but it does not provide high therapeutic efficacy in all patients. Therefore, identifying predi
Externí odkaz:
https://doaj.org/article/e2d13ac42f2241c58d640698425031f0
Autor:
Kimihiro Yonemitsu, Cheng Pan, Yukio Fujiwara, Yuko Miyasato, Takuya Shiota, Hiromu Yano, Seiji Hosaka, Koji Tamada, Yutaka Yamamoto, Yoshihiro Komohara
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Ever since immune checkpoint inhibitors have been approved for anti-cancer therapy in several cancers, including triple-negative breast cancer, the significance of programmed death-1 ligand 1 (PD-L1) expression in the tumor immune microenvir
Externí odkaz:
https://doaj.org/article/72fd4466705c4a23a3d0b095fee56317